Park, J., Novartis Pharmaceuticals Corporation, United States

• Vol 23, No 4 (2016) - Medical Economics
  Cost-effectiveness of pazopanib compared with sunitinib in metastatic renal cell carcinoma in Canada
  Abstract  PDF  HTML

Copyright © 2019 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)